Cart (0 Items)
Your cart is currently empty.
View Products
In peptide production, there’s no one-size-fits-all solution. Chemical and microbial recombinant production technologies are recurrently used and combined in an attempt to maximize production yields and increase the purity of…
As of June 2, 2020, there are 10 COVID-19 candidate vaccines in clinical evaluation. These candidates are based on 5… Read More
Vaccines could help us curb the COVID-19 pandemic. But vaccine efficiency can be difficult to assess during early clinical trials. Read More
More than a century ago, the world faced the most devastating pandemics in history – the Spanish flu. Caused by… Read More
Throughout his impressive career, Professor Istvan Toth has pursued the optimization and simplification of current vaccine and drug delivery systems. Read More
For the past decade, protein analysis has evolved from difficult gel-based separations to advanced mass spectrometry technologies. Today, there are… Read More
Peptides are uniquely poised between small and large molecules and, therefore, their unique structure and reactivity makes them desirable for… Read More
Therapeutic peptides are getting longer and increasingly complex. This has led to the rise in production and purification costs. On… Read More
GMP peptide synthesis regulations ensure the safety of the final product for end-user applications. Currently, the greatest challenge encountered during… Read More
The beneficial properties of peptides have been known for more than a century. But only in the last decades has… Read More